Please login to the form below

Not currently logged in
Email:
Password:

Ligand Pharmaceuticals

This page shows the latest Ligand Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

GSK signs collaboration deal with Ligand targeting neurological disorders

GSK signs collaboration deal with Ligand targeting neurological disorders

GlaxoSmithKline (GSK) has signed a collaboration and licence agreement with Ligand Pharmaceuticals’ subsidiary Icagen to develop small molecule therapeutics targeting neurological diseases. ... The Ligand agreement is the latest in a string of deals

Latest news

  • Retrophin rockets away as rare disease trial hits targets Retrophin rockets away as rare disease trial hits targets

    Sparsentan was brought into Retrophin's pipeline by Shkreli in 2012 - who licensed it from Ligand Pharmaceuticals - and combines angiotensin receptor blockade with endothelin receptor blockade, both mechanisms already exploited by

  • Generic for Lilly's Evista in US 'within a month' Generic for Lilly's Evista in US 'within a month'

    Could Duavee fill the void? The genericisation of Evista also provides an opportunity for Pfizer and partner Ligand Pharmaceuticals, whose Duavee (conjugated oestrogens and bazedoxifene) - formerly known as Aprela - was approved

  • CURx buys rights to Gilead’s lung infection drug CURx buys rights to Gilead’s lung infection drug

    Agrees deal for fosfomycin/tobramycin combination. CURx Pharmaceuticals has acquired the rights to Gilead Sciences' investigational drug for a lung infection associated with cystic fibrosis. ... It adds to CURx' existing limited portfolio, which so far

  • GSK's Revolade cleared for use in hepatitis C therapy GSK's Revolade cleared for use in hepatitis C therapy

    GSK pays single-digit royalties on sales of the drug to Ligand Pharmaceuticals of the US, whose chief executive John Higgins, said recently that 2013 sales are expected to reach around

  • Drug delivery

    In addition, Ligand may have to make payments to Prism Pharmaceuticals, the previous holder of the programme. . ... GSK/Adolor. Enetereg for gut recovery post-surgery. Reacquisition of rights. 25. Ligand Pharmaceuticals/The Medicines Company.

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • Deal Watch table for June 2014 Deal Watch table for June 2014

    630. DAVA Pharmaceuticals/ Endo International. Company acquisition. Generics business including generic Doxycycline and Cefdinir. ... 232. Ligand Pharmaceuticals/ TG Therapeutics. Exclusive global licence. Development, commercialisation of Interleukin-1

  • Pharma deals during March 2013 Pharma deals during March 2013

    Chinese traditional medicines and Western medicines. 70.5. Ligand Pharmaceuticals/ Spectrum Pharmaceuticals. ... Astellas Pharma/ Cubist Pharmaceuticals ††. Acquisition of rights. Ceftolozane for complicated Gram-negative infections.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Former Pfizer R&D head LaMattina to advise Ziarco Former Pfizer R&D head LaMattina to advise Ziarco

    In addition to his role at Ziarco, LaMattina is a senior partner at PureTech Venues and serves on the board of directors at Ligand Pharmaceuticals and the scientific advisory board of ... Trevena Pharmaceuticals.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....